Roger S. McIntyre, MD, FRCPC, shares the backstory and pharmacology of incretins to better understand the role of GLP-1 RAs in psychiatry.

New research reveals ketamine's safe use for treating eating disorders, offering hope for patients with comorbid treatment-resistant depression.

Sara Robinson, DNP, RN, PMHNP-BC, provides insight on considerations surrounding prescribing psychiatric medications for perinatal patients.

Researchers analyze single-cell communication in brains of people with PTSD, uncovering genetic variations that could lead to new treatments for this complex disorder.

Explore essential insights and best practices in geriatric psychiatry in our July theme! Submit your insights, tips, and case studies centered on healthy aging for older adults.

These 2 compelling memoirs delve into the complexities of schizophrenia, showcasing resilience, friendship, and the impact of mental health.

New clinical trial results reveal BPL-003's rapid and durable antidepressant effects, paving the way for innovative treatments in treatment-resistant depression.

The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals.

Doctors in India face escalating burnout and violence, risking their well-being while navigating a broken health care system. This Doctor's Day, reform is urgently needed.

New research reveals how ezogabine targets potassium channels in the brain, offering innovative treatment options for major depressive disorder symptoms.

Discover how PAs like Erin Crown, MHS, PA-C, Psych-CAQ, are transforming mental health care, bridging gaps, and expanding access to psychiatric services nationwide.

Check out the pipeline updates from June!

Panelists discuss the critical importance of early diagnosis and personalized treatment in narcolepsy, using a case study to illustrate how tailored therapy—considering patient preferences, comorbidities, and lifestyle factors—can improve engagement, safety, and long-term outcomes.

Panelists discuss the evolving treatment landscape for narcolepsy, highlighting the growing availability of personalized therapies, persistent challenges with diagnosis and access, and the importance of clinician advocacy and education to ensure timely, individualized care for patients.

Panelists discuss how non-stimulant medication options with detailed clinical considerations.

Panelists discuss how comprehensive treatment approaches emphasize combination therapy and immediate implementation.

Alto Neuroscience's ALTO-203 trial reveals mixed results, highlighting potential biomarkers for targeted depression treatment despite missing primary efficacy goals.

Rebecca Barbee, PA-C, shares tips on addressing the heat wave and its implications when talking with patients.

"As Saint Francis put his hand on the creased forehead of the sow, and told her in words and in touch blessings of earth on the sow..."

Explore the intriguing connections between afterlife beliefs, personal experiences, and the psychological impact of grief in this thought-provoking analysis.

Researchers uncover a novel biomarker for major depressive disorder, linking regional homogeneity in fMRI to decreased cerebral blood flow and symptom severity.

Augmented reality can transform psychiatric treatment, enhancing exposure therapy for trauma and anxiety by simulating real-world environments and interactions.

The complex ethics of dying, death, and assisted dying lead to debates on terminology and implications for patient autonomy and suffering.

July 1 marks 50 years in psychiatry for H. Steven Moffic, MD! In celebration, he shares essential advice for aspiring psychiatrists, emphasizing ethical decision-making, flexibility, and the importance of passion in mental health careers.

In this CME article, learn more about the complexities of neuropsychiatric symptoms in Parkinson disease, including psychosis and cognitive impairment, and effective treatment strategies.